Australia markets closed

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
43.54-1.47 (-3.27%)
At close: 1:00PM EST
43.54 0.00 (0.00%)
After hours: 01:01PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts1581415
Avg. Estimate-1.43-1.33-8.74-5.23
Low estimate-2.18-1.53-9.49-6.31
High estimate-0.41-0.78-7.68-3.15
Year ago EPS0.93-2.32-4.59-8.74
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts1571616
Avg. Estimate13.98M25.28M20.78M131.7M
Low estimate5.64M7M11.91M38.38M
High estimate70M78.61M76M293.27M
Year ago sales250MN/A250.65M20.78M
Sales growth (year/est)-94.40%N/A-91.70%533.80%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.75-1.62-1.69-1.7
Actual EPS0.93-2.32-2.72-2.28
Difference1.68-0.7-1.03-0.58
Surprise %224.00%-43.20%-60.90%-34.10%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-1.43-1.33-8.74-5.23
7 days ago-1.43-1.36-8.74-5.29
30 days ago-1.51-1.67-8.18-6.08
60 days ago-1.53-1.62-8.11-6
90 days ago-1.53-1.66-8.11-5.91
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 days10111
Up last 30 days128212
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2N/A11N/A
Growth estimatesAPLSIndustrySector(s)S&P 500
Current qtr.-253.80%N/AN/AN/A
Next qtr.42.70%N/AN/AN/A
Current year-90.40%N/AN/AN/A
Next year40.20%N/AN/AN/A
Next 5 years (per annum)33.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A